SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alliance Pharmaceutical -- Ignore unavailable to you. Want to Upgrade?


To: Alok Sinha who wrote (340)4/1/1999 8:20:00 PM
From: Cacaito  Read Replies (1) | Respond to of 548
 
Hextend approval by FDA for hypovolemia from blood loss.

Abbott Labs will market it for the small biotech.

I need to find more about this product. It is not an oxygen carrier as far as I know, it just support blood pressure and perfusion by increasing plasma volume. Somewhat similar to others already in the market and not widely use.